These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 18227855)
1. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer. Lu T; Hano H Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855 [TBL] [Abstract][Full Text] [Related]
2. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers. Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266 [TBL] [Abstract][Full Text] [Related]
3. Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers. Lu W; Takahashi H; Furusato B; Maekawa S; Ikegami M; Sudo A; Egawa S; Hano H Genes Chromosomes Cancer; 2006 May; 45(5):509-15. PubMed ID: 16470536 [TBL] [Abstract][Full Text] [Related]
4. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Ittmann MM Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052 [TBL] [Abstract][Full Text] [Related]
6. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of proximal 6q deletions in prostate cancer. Cooney KA; Wetzel JC; Consolino CM; Wojno KJ Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584 [TBL] [Abstract][Full Text] [Related]
8. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer. Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610 [TBL] [Abstract][Full Text] [Related]
9. [Allelic loss of 6q16.3 microsatellite DNA in childhood acute lymphoblastic leukemia and bioinformatics analysis]. Yang MH; Cao LZ; Yu Y; Zhang ZX; Wang Y; Kang R; Chen Y; Tan ZH; Wu XS Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):289-93. PubMed ID: 16875573 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia]. Wang Z; Lai FM Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203 [TBL] [Abstract][Full Text] [Related]
12. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322 [TBL] [Abstract][Full Text] [Related]
13. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13. Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291 [TBL] [Abstract][Full Text] [Related]
14. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA; Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer. Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310 [TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935 [TBL] [Abstract][Full Text] [Related]
17. Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1. Carvalho B; Seruca R; Carneiro F; Buys CH; Kok K Genes Chromosomes Cancer; 1999 Sep; 26(1):29-34. PubMed ID: 10441002 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer. Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480 [TBL] [Abstract][Full Text] [Related]
19. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026 [TBL] [Abstract][Full Text] [Related]
20. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Komiya A; Suzuki H; Ueda T; Yatani R; Emi M; Ito H; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):245-53. PubMed ID: 8946206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]